DAA2279 |
CD163 molecule increases with age |
Molecular |
parietal lobe |
Human |
CD163 |
488.1% Increase Gene Expression Level |
|
DAA2369 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
135.3% Increase Gene Expression Level |
|
DAA2264 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
parietal lobe |
Human |
CASP1 |
53.3% Increase Gene Expression Level |
|
DAA2138 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
Molecular |
temporal lobe |
Human |
FCGR1A |
151.0% Increase Gene Expression Level |
|
DAA2203 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
56.5% Increase Gene Expression Level |
|
DAA1096 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
temporal lobe |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA2135 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
193.5% Increase Gene Expression Level |
|
DAA2331 |
major histocompatibility complex, class I, E increases with age |
Molecular |
hippocampus |
Human |
HLA-E |
39.2% Increase Gene Expression Level |
|
DAA2165 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
39.5% Increase Gene Expression Level |
|
DAA2373 |
major histocompatibility complex, class I, B increases with age |
Molecular |
hippocampus |
Human |
HLA-B |
44.0% Increase Gene Expression Level |
|
DAA2315 |
major histocompatibility complex, class II, DP alpha 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPA1 |
262.9% Increase Gene Expression Level |
|
DAA1104 |
Myogenic Differentiation 1 |
Molecular |
temporal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA2280 |
CD163 molecule increases with age |
Molecular |
parietal lobe |
Human |
CD163 |
491.5% Increase Gene Expression Level |
|
DAA2367 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
parietal lobe |
Human |
HLA-DRB5 |
95.8% Increase Gene Expression Level |
|
DAA2359 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
hippocampus |
Human |
HLA-DRA |
324.5% Increase Gene Expression Level |
|
DAA2256 |
Thioredoxin interacting protein increases with age |
Molecular |
parietal lobe |
Human |
TXNIP |
143.1% Increase Gene Expression Level |
|
DAA2356 |
major histocompatibility complex, class II, DP beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPB1 |
13.2% Increase Gene Expression Level |
|
DAA2295 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
temporal lobe |
Human |
CX3CL1 |
46.7% Decrease Gene Expression Level |
|
DAA2371 |
major histocompatibility complex, class II, DR beta 4 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB4 |
88.5% Increase Gene Expression Level |
|
DAA2230 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
parietal lobe |
Human |
MYD88 |
54.8% Increase Gene Expression Level |
|
DAA2349 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
22.4% Increase Gene Expression Level |
|
DAA2306 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
parietal lobe |
Human |
CXCL16 |
78.9% Increase Gene Expression Level |
|
DAA2200 |
complement factor H increases with age |
Molecular |
frontal lobe |
Human |
CFH |
210.8% Increase Gene Expression Level |
|
DAA2287 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
283.0% Increase Gene Expression Level |
|
DAA2242 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
frontal lobe |
Human |
MYD88 |
58.7% Increase Gene Expression Level |
|